Esya Labs - About the company
Esya Labs is a seed company based in United Kingdom, founded in 2017. It operates as a Developer of nanotechnology-based nucleic acid diagnostics for early detection of diseases. Esya Labs has raised $217K in funding. The company has 230 active competitors, including 58 funded and 48 that have exited. Its top competitors include companies like 10X Genomics, Nanopore Technologies and PacBio.
Company Details
Developer of nanotechnology-based nucleic acid diagnostics for early detection of diseases. The company intends to develop the technology for the early and safe diagnosis of rare genetic diseases.
- Website
- www.esyalabs.com/
- Registered Address
- IMPERIAL WHITE CITY INCUBATOR TRANSLATION AND INNOVATION ( I-HUB),84 WOOD LANE,LONDON,ENGLAND,W12 0BZ
Key Metrics
Founded Year
2017
Location
Stage
Seed
Total Funding
$217K in 2 rounds
Latest Funding Round
Ranked
124th among 230 active competitors
Employee Count
5 as on Apr 30, 2026
Similar Companies
Legal entities associated with Esya Labs
Esya Labs is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ESYA LTD CIN: 10916289 , United Kingdom, Active | Aug 14, 2017 | - | 5 (As on Dec 31, 2024) |
Sign up to download Esya Labs' company profile
Esya Labs's funding and investors
Esya Labs has raised a total funding of $217K over 2 rounds. Its first funding round was on Jun 10, 2019.
Here is the list of recent funding rounds of Esya Labs:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 13, 2022 | 4339686 | Seed | 1413630 | 2709290 | 3665874 | 1826972 |
Jun 10, 2019 | 1126244 | Seed | 6928232 | 6116663 | 3372003 | 9232907 |
View details of Esya Labs's funding rounds and investors
Esya Labs' founders and board of directors
Founder? Claim ProfileEsya Labs' employee count trend
Esya Labs has 5 employees as of Apr 26. Here is Esya Labs's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Esya Labs's Competitors and alternates
Top competitors of Esya Labs include 10X Genomics, Nanopore Technologies and PacBio. Here is the list of Top 10 competitors of Esya Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | 10X Genomics 2012, Pleasanton (United States), Public | Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis | $243M | 77/100 | |
2nd | Nanopore Technologies 2005, Oxford (United Kingdom), Public | Manufacturer of portable and benchtop devices for real-time DNA sequencing | $1.26B | 75/100 | |
3rd | PacBio 2004, Menlo Park (United States), Public | Developer of instrument systems and software for real-time sequencing of single-molecules | $410M | 72/100 | |
4th | Complete Genomics 2006, San Jose (United States), Acquired | Developer of DNA sequencing platform for human genome sequencing and analysis | $125M | 66/100 | |
5th | Element Biosciences 2017, San Diego (United States), Series D | Developer of benchtop DNA sequencer for research applications | $678M | 64/100 | |
6th | Ultima Genomics 2016, Newark (United States), Series D | Developer of high-throughput NGS instrument for research | $600M | 63/100 | |
7th | Singular Genomics 2016, San Diego (United States), Acquired | Provider of next-generation gene sequencing and multi-omics technologies | - | 60/100 | |
8th | S2 Genomics 2016, Livermore (United States), Acquired | Developer of automated sample preparation systems for genomics | $16M | 59/100 | |
9th | 3billion 2016, Seoul (South Korea), Public | Provider of AI-driven clinical diagnostic testing platform for rare genetics disease | $46M | 58/100 | |
10th | Bionano 2002, San Diego (United States), Public | Provider of genome analysis solutions to researchers and clinicians | $124M | 58/100 | |
124th | Esya Labs 2017, United Kingdom, Seed | Developer of nanotechnology-based nucleic acid diagnostics for early detection of diseases | $217K | - | 28/100 |
Looking for more details on Esya Labs's competitors? Click here to see the top ones
Esya Labs's Investments and acquisitions
Esya Labs has made no investments or acquisitions yet.
News related to Esya Labs
•
•
Esya Labs Provides Novel Research Assays to Accelerate Drug Discovery EffortsBusiness Wire•Apr 06, 2021•Esya Labs
Are you a Founder ?
FAQs about Esya Labs
Explore our recently published companies
- Jamesmearchent - United Kingdom based, Unfunded company
- Alphascaffolding - United Kingdom based, Unfunded company
- Natuerlichimholzhaus - Germany based, Unfunded company
- North W Roofing - United Kingdom based, Unfunded company
- Constructec - Palma based, Unfunded company
- Halasbau - Buch Am Erlbach based, Unfunded company